This compound is a pharmaceutical intermediate used in the synthesis of ozanimod, a medication for autoimmune conditions. It features a nitrile group and a stereocenter, indicating its role in building complex molecular structures for drug development.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1306763-31-4
3-((2-Chloromethyl-1-methyl-1H-benzimidazole-5-carbonyl)-pyridine-2-yl-amino)-propionic acid ethyl ester
Pharmaceutical intermediate for drug synthesis
2-Bromo-6-nitrophenol
pharmaceutical intermediate
Fmoc-D-Arg-OH
Peptide synthesis intermediate
3-oxo-8-aza-bicyclo[3.2.1]octane-8-carboxylic acid benzyl ester
pharmaceutical intermediate for tropane alkaloids
(S)-1-Amino-2,3-dihydro-1H-indene-4-carbonitrile hydrochloride
pharmaceutical intermediate for synthesis
(R)-1-Aminoindane-d3 Hydrochloride
deuterated pharmaceutical research standard
(1R,2S)-(+)-cis-1-Amino-2-indanol
Pharmaceutical intermediate for chiral synthesis
5-bromo-2,3-dihydro-1H-inden-4-amine
research compound
tert-butyl N-[(1S)-4-cyano-2,3-dihydro-1H-inden-1-yl]carbamate
LBHMMDUJKBJVQI-ZDUSSCGKSA-N
CC(C)(C)OC(=O)N[C@H]1CCC2=C(C=CC=C12)C#N